Novavax Nabs $1.6B, BD Secures Fast Antigen Test OK, & a Tribute to Tony Fauci

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

Remdesivir’s FDA Approval, Moderna Fully Enrolls & FDA Wrestles With Trust
J&J Vaccine Study Paused, Lilly Antibody Paused, and Regeneron’s Ebola FDA Approval
A Historic Nobel for CRISPR, Pfizer Sticks Up for FDA, & a CDC Legend Speaks
FDA Commissioners Speak Out, An Antibiotic Incentive Proposal and a Drug Price Grilling